appengine.ai

Artificial Intelligence | Machine Learning Medical 21 | Reshaping the Future of Cardiac Bypass Surgery


Enterprise, Medical Devices, Healthcare, Bypass Surgery, Manufacturing, Treatment, Patient Care Minneapolis, MN, United States

Medical 21

Artificial Intelligence | Machine Learning


Medical 21 | Reshaping the Future of Cardiac Bypass Surgery

Medical 21

Medical Devices, Healthcare, Bypass Surgery, Manufacturing, Treatment, Patient Care


Minneapolis, MN, United States

Medical 21 develops and manufactures artificial graft for coronary bypass surgery to eliminate the "harvesting" of vessels for cardiac bypass surgery - improving the quality of life for patients, and reducing costs for the healthcare system. There are over 800,000 heart bypass surgeries performed annually. For each of those surgeries, the surgical team needs to perform a second procedure, either on the patient's legs or arms, to harvest vessels that will be used for the bypasses.That second surgery can result in pain, additional scarring, and other complications for the patient.  If there is an infection, it can lead to an exponential increase in cost. An artificial bypass graft will eliminate the need for this second surgery, making it easier for patients and less expensive for the healthcare system.

Medical 21, Inc. is a developmental stage medical device company founded by Dr. Manny Villafaña and located in Minneapolis, MN.  We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart.

 

B2B

1000+

Funded

$3,500,000

Scaling Up

2016

 
 

Medical Devices
Healthcare

N/A

Reduce Operational Cost
Increase Efficiency

 
 

Production
Service

Yes

Active

 
 

   Machine Learning


Medical Devices

Medical Devices


Image

Image

Video

Video

Text

Text

Time Series

Time Series

 

   Hardware


N/A


N/A

 
 
Manny Villafana


Manny Villafana
Chairman & CEO